RU2014139441A - COMPOSITION AND METHOD FOR PRODUCING EYE DROPS - Google Patents
COMPOSITION AND METHOD FOR PRODUCING EYE DROPS Download PDFInfo
- Publication number
- RU2014139441A RU2014139441A RU2014139441A RU2014139441A RU2014139441A RU 2014139441 A RU2014139441 A RU 2014139441A RU 2014139441 A RU2014139441 A RU 2014139441A RU 2014139441 A RU2014139441 A RU 2014139441A RU 2014139441 A RU2014139441 A RU 2014139441A
- Authority
- RU
- Russia
- Prior art keywords
- solution
- cooling
- followed
- preparing
- boric acid
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция в виде глазных капель для местного лечения воспалительных заболеваний глаз микробного генеза и бактериальных инфекций у людей или животных, включающая антибактериальное хинолоновое соединение и целевые добавки, отличающаяся тем, что не содержит консерванты, а в качестве антибактериального хинолонового соединения выбрано одно из соединений ряда хинолонов, а именно ломефлоксацин, или норфлоксацин, или пефлоксацин, или левофлоксацин, или спарфлоксацин, или моксифлоксацин, или гатифлоксацин, или гемифлоксацин, или их приемлемые соли при следующем соотношении компонентов, мас. %:2. Способ получения фармацевтической композиции по п. 1, включающий приготовление водного раствора метилцеллюлозы при температуре 80-90°С с последующим охлаждением до комнатной температуры, приготовление раствора борной кислоты при температуре 75-85°С с последующим охлаждением раствора до 50-60°С, растворение фторхинолонового соединения и натрия хлорида в растворе борной кислоты с последующим охлаждением до комнатной температуры, введение водного раствора метилцеллюлозы, гомогенизация приготовленного раствора, доведение раствора гидроксидом натрия до рН 6-8, проведение стадии стерилизующей фильтрации и асептического розлива.3. Способ получения фармацевтической композиции по п. 1, включающийприготовление водного раствора гидроксипропилметилцеллюлозы при комнатной температуре, приготовление раствора борной кислоты при температуре 75-85°С с последующим охлаждением раствора до 50-60°С, растворение фторхинолонового соединения и натрия хлорида в растворе борной кислоты с последующим охлаждением до комнатной температуры, введение в1. A pharmaceutical composition in the form of eye drops for topical treatment of inflammatory eye diseases of microbial origin and bacterial infections in humans or animals, including an antibacterial quinolone compound and target additives, characterized in that it does not contain preservatives, and one of the compounds is selected as an antibacterial quinolone compound a number of quinolones, namely lomefloxacin, or norfloxacin, or pefloxacin, or levofloxacin, or sparfloxacin, or moxifloxacin, or gatifloxacin, or hemiflox in, or their acceptable salts in the following ratio, wt. %: 2. A method of obtaining a pharmaceutical composition according to claim 1, comprising preparing an aqueous solution of methyl cellulose at a temperature of 80-90 ° C, followed by cooling to room temperature, preparing a solution of boric acid at a temperature of 75-85 ° C, followed by cooling of the solution to 50-60 ° C, dissolving the fluoroquinolone compound and sodium chloride in a boric acid solution, followed by cooling to room temperature, introducing an aqueous solution of methyl cellulose, homogenizing the prepared solution, adjusting the hydroxide solution ohm of sodium to a pH of 6-8, the stage of sterilizing filtration and aseptic filling. 3. A method of obtaining a pharmaceutical composition according to claim 1, comprising preparing an aqueous solution of hydroxypropyl methylcellulose at room temperature, preparing a solution of boric acid at a temperature of 75-85 ° C, followed by cooling the solution to 50-60 ° C, dissolving the fluoroquinolone compound and sodium chloride in a solution of boric acid with subsequent cooling to room temperature, introduction to
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014139441/15A RU2595837C2 (en) | 2014-09-29 | 2014-09-29 | Composition and method of producing eye drops |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014139441/15A RU2595837C2 (en) | 2014-09-29 | 2014-09-29 | Composition and method of producing eye drops |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014139441A true RU2014139441A (en) | 2016-04-20 |
RU2595837C2 RU2595837C2 (en) | 2016-08-27 |
Family
ID=55789241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014139441/15A RU2595837C2 (en) | 2014-09-29 | 2014-09-29 | Composition and method of producing eye drops |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2595837C2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR020661A1 (en) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
JPWO2002040028A1 (en) * | 2000-11-16 | 2004-03-18 | わかもと製薬株式会社 | Antibacterial gel eye drops |
WO2005000307A1 (en) * | 2003-06-26 | 2005-01-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition containing quinolones and method of use |
ITMI20080289A1 (en) * | 2008-02-22 | 2009-08-23 | S I F I Societa Industria Farmaceutica Italia | COMPOSITIONS OF GEMIFLOXACINE WITH HIGH EFFICIENCY ON EYE DISEASES |
KR20140022900A (en) * | 2011-04-22 | 2014-02-25 | 알콘 리서치, 리미티드 | Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
-
2014
- 2014-09-29 RU RU2014139441/15A patent/RU2595837C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2595837C2 (en) | 2016-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120248T1 (en) | IMIDAZO COMPOUNDS [4,5-C] KINOLIN-2-ONE AND THEIR USE IN CANCER TREATMENT | |
EA201200318A1 (en) | Heterocyclic oximes | |
JP2012107046A5 (en) | ||
EA201491672A1 (en) | HETEROCYCLINE COMPOUNDS AS MEK INHIBITORS | |
PH12012502568A1 (en) | Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts | |
EA201200260A1 (en) | HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION | |
EA201390626A1 (en) | DERIVATIVES OF HYDROXAMIC ACID AND APPLICATION OF INDICATED DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS | |
PH12015501891A1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
BR112015006568A2 (en) | lactic acid bacteria and compositions | |
EA033054B1 (en) | Glutarimide derivative, use thereof, pharmaceutical composition based thereon, methods for producing same | |
PH12015501890A1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
BR112015017100A2 (en) | Process for the preparation of the antitumor agent 6- (7 - ((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -n-methyl-1-naphtamide and its crystalline lens | |
EA202190445A2 (en) | ORAL SOLUTION | |
BR112019003320A2 (en) | heteroaryl carboxamide compounds as ripk2 inhibitors | |
EA201491982A1 (en) | ANTIBACTERIAL QUINOLINE DERIVATIVES | |
EA201100754A1 (en) | [4- (1-AMINOETHYL) CYCLOGEXYL] METHYLAMINES AS ANTIBACTERIAL MEANS | |
MX366894B (en) | ANTIMICROBIAL COMPOSITIONS and METHODS FOR THEIR PRODUCTION. | |
RU2014139441A (en) | COMPOSITION AND METHOD FOR PRODUCING EYE DROPS | |
SI2999707T1 (en) | Tylosin derivatives and method for preparation thereof | |
CN105687126A (en) | Veterinary levofloxacin injection, and preparation method thereof | |
EA201891934A1 (en) | NEW IMMUNOBIOLOGICAL PRODUCTS | |
MX2022011565A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
NO20092541L (en) | Antibacterial quinoline derivatives | |
MX2013013286A (en) | Formula and method for preparing ophthalmic solutions derived from quinolones and a protease enzyme with anti-inflammatory and analgesic properties. | |
RU2013141085A (en) | EXTERIOR COMBINED MEANS FOR TREATMENT OF VARIOUS ACNE FORMS |